Regenexx Quotes Prices During Patient Consultations Instead of Publishing Set Rates

Regenexx does not publish standard prices online, requiring patients to attend a consultation to receive a quote. At Medical Frontier, we set out what clinics publish and what independent reporting shows before you pay for an unproven treatment. While the network does not post pricing, third-party reporting indicates that Regenexx injections ranged from $1,500 to $9,000 as of 2019.

Insurers such as Aetna list these injections as experimental, though some employers include a Regenexx benefit in their health plans.

How Much Regenexx Costs

Regenexx does not publish fixed dollar prices on its website and calculates billing totals during a patient consultation appointment. According to the official Regenexx FAQ, each treatment plan is customized based on individual anatomy, clinical severity, and the specific biological product recommended by the treating clinician. A clinic will quote the exact fee only after a physician evaluates your joints or spine in person.

Because the licensed clinic network does not list prices publicly, patients must rely on third-party investigative reports and independent medical reviews for historical price ranges. In an investigation published on June 20, 2019, KFF Health News reported that injections across the network ranged from $1,500 to $9,000. In that same report, one patient shared that she paid $7,700 in 2018 to treat an injured ligament at a licensed clinic in Colorado. Similarly, cell biology researcher Paul Knoepfler cited the same $1,500 to $9,000 range on The Niche, while cautioning that patients requiring multiple follow-up appointments face higher total expenses. Because these figures reflect reporting from 2018 and 2019, current clinic quotes may differ.

The specific biological method selected for your care directly dictates where your quote lands within that price spectrum:

• Regenexx SCP (Super Concentrated Platelets): This is a blood-based platelet-rich plasma (PRP) procedure. Regenexx notes in its FAQ that platelet procedures using SCP injectate cost considerably less than procedures using bone marrow concentrate.
• Regenexx SD (Same Day): This is a bone marrow concentrate (BMC) procedure.

Regenexx Prices Next to Other Options

Evaluating a private quote requires understanding how branded network pricing compares to broader market averages for autologous biologics.

Outside the licensed network, general market surveys reveal an expansive pricing range for joint injections. A 2018 peer-reviewed survey conducted by a Cleveland Clinic research team and published in the Journal of Knee Surgery reviewed 65 commercial clinics selling knee stem cell injections. The survey identified an average cash fee of $5,156 for knee therapy, with individual clinic pricing ranging from $1,150 up to $12,000. That academic survey examined general commercial providers rather than the branded network specifically, but it illustrates the out-of-pocket range typical of cash-pay regenerative orthopedics.

As documented in our overview of bone marrow aspirate concentrate, patients receiving autologous cellular injections nationwide typically pay between $3,000 and $8,000 for a single joint. Multiple joints or spinal injections commonly increase those out-of-pocket bills to $6,000 to $15,000. Standard platelet treatments run between $400 and $2,000 per single session, with complete multi-injection regimens totaling $1,500 to $6,000, as detailed in our PRP injection cost guide.

What Insurance and Employers Pay

Standard commercial health plans do not pay for Regenexx cellular injections. Major private insurers classify orthopedic cellular therapy as experimental, investigational, or unproven.

In Clinical Policy Bulletin 0411, private insurer Aetna explicitly designates “Mesenchymal stem cell therapy (e.g., AlloStem, Osteocel, Osteocel Plus, Ovation, Regenexx, and Trinity Evolution)” as experimental and unproven for all orthopedic uses. The bulletin applies the same experimental exclusion to general bone marrow aspirate when used for joint conditions like osteoarthritis. In its 2019 report, KFF Health News noted that commercial payer Anthem similarly categorizes regenerative joint injections as not medically necessary, while Aetna dismisses both stem cell and platelet injections as experimental. For patients navigating major commercial policies, our analysis of Blue Cross Blue Shield coverage outlines how Blue Cross plans treat these claims.

Public health programs follow the same payment restrictions. According to the Regenexx FAQ, neither Medicare nor Medicaid chooses to cover regenerative procedures. Patients covered by traditional Medicare, Medicare Advantage, or state Medicaid programs must assume complete financial responsibility for any regenerative injection administered at a network facility.

However, an alternative payment route exists for certain commercially insured employees. Some self-funded corporate employers partner directly with Regenexx to carve out specific regenerative benefits. On its employer-facing site, Regenexx Corporate states that its program is trusted by over 2,000 employers, expanding on the 100 employers reported by KFF Health News in 2019. Under these specialized agreements, a participating company agrees to sponsor employee injections directly, promoting the outpatient procedure as a lower-cost option compared to major joint replacement surgery.

If your employer does not maintain an active direct agreement, the Regenexx FAQ says medical insurance may cover these line items:

• Initial clinician evaluation visits and physical examinations
• Diagnostic imaging such as clinic X-rays or magnetic resonance imaging (MRI)
• Diagnostic testing, if recommended
• Physical therapy regimens recommended before or after treatment
• Post-procedure medical bracing and joint supports

Your plan bills those auxiliary services under normal deductibles, copayments, and coinsurance terms. The injection fee itself remains entirely self-pay unless your human resources department confirms an active, contracted corporate benefit.

The Cayman Islands Site and the 2014 Court Case

Regenexx’s location directory lists an international treatment center in George Town, Grand Cayman. This Caribbean facility offers medical protocols distinct from those administered at United States clinics, specifically procedures utilizing cultured mesenchymal stem cells.

Under United States law, the Food and Drug Administration (FDA) strictly restricts how clinics process human biological tissues. In United States v. Regenerative Sciences, LLC, decided on February 4, 2014, the U.S. Court of Appeals for the D.C. Circuit affirmed a permanent injunction regarding Regenexx’s domestic “Cultured Regenexx Procedure.” The appellate court held that a mixture of a patient’s stem cells and the antibiotic doxycycline was a drug subject to federal laws regulating drugs and biological products.

KFF reported in 2019 that Regenexx performs its cultured-cell procedure only in the Cayman Islands, where the government allows it.

Questions to Ask at the Consultation

Because network clinics establish final pricing during individual evaluations, you must prepare specific financial and administrative questions before attending your appointment. Using our guide on how to vet a clinic will help you evaluate both clinical quality and administrative billing integrity.

Take this checklist to your initial consultation:

• Which exact procedure is being recommended? Clarify whether the physician is recommending a blood-based platelet procedure (SCP) or a bone marrow concentrate procedure (SD), as the two methods carry vastly different price tags.
• What is the complete itemized cost? Request a written document listing the doctor’s injection fee, processing and laboratory charges, imaging guidance fees, and facility costs.
• How many injections are included in the quote? Ask whether the quoted number covers a single session or an entire multi-injection protocol, and establish the cash cost of any necessary repeat injections.
• Does my specific employer plan include an active benefit? Verify with the billing staff whether your employer maintains a direct contract through the corporate network, and confirm that status with your human resources department.
• What parts of the visit will be billed to commercial insurance? Confirm which services will be submitted to your private insurance plan (such as consultations, imaging, or bracing) and verify your expected deductible and coinsurance obligations.

Evaluating the Final Quote

Regenexx does not publish fixed procedure prices, meaning patients receive an exact financial quote only after completing an in-person medical evaluation. KFF Health News reported in 2019 that Regenexx injections ranged from $1,500 to $9,000.

Because commercial insurers and Medicare exclude orthopedic cellular therapy as experimental, you must anticipate paying the entire injection fee yourself unless your employer provides a specific corporate benefit rider. Review the interactive cost estimator to compare typical out-of-pocket price bands for joint procedures across the United States.